Sequent Scientific Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Net Loss of Sequent Scientific reported to Rs 0.91 crore in the quarter ended March 2024 as against net loss of Rs 93.58 crore during the previous quarter ended March 2023. Sales declined 1.49% to Rs 361.20 crore in the quarter ended March 2024 as against Rs 366.67 crore during the previous quarter ended March 2023.

For the full year,net loss reported to Rs 35.87 crore in the year ended March 2024 as against net loss of Rs 121.16 crore during the previous year ended March 2023. Sales declined 3.60% to Rs 1369.73 crore in the year ended March 2024 as against Rs 1420.91 crore during the previous year ended March 2023.

Powered by Capital Market - Live News

Sequent Scientific will hold a meeting of the Board of Directors of the Company on 15 May 2024

Powered by Capital Market - Live News

Sequent Scientific announced that Sharat Pandurang Narasapur has resigned as a Jt. Managing Director from the Board of Directors of the Company, with effect from the close of business hours on 30 April 2024.

Powered by Capital Market - Live News

Net profit of Sequent Scientific reported to Rs 8.27 crore in the quarter ended December 2023 as against net loss of Rs 8.87 crore during the previous quarter ended December 2022. Sales declined 12.24% to Rs 329.36 crore in the quarter ended December 2023 as against Rs 375.31 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News